MKRN1/2 serve as tumor suppressors in renal clear cell carcinoma by regulating the expression of p53

CONCLUSIONS: Our study suggests that MKRN1 and MKRN2 serve as tumor suppressors in KIRC, and act as promising therapeutic targets for KIRC treatment.PMID:36938725 | DOI:10.3233/CBM-210559

Source: Cancer Biomarkers - March 20, 2023 Category: Cancer & Oncology Authors: Yun Yang Yanyan Luo Shuting Huang Yonghui Tao Chuanyin Li Chengcheng Wang Source Type: research